Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery with Cardio-Pulmonary Bypass
This study is ongoing, but not recruiting participants.
Study NCT00048308   Information provided by Alexion Pharmaceuticals
First Received: October 29, 2002   Last Updated:   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardio-pulmonary Bypass
Coronary Artery Bypass Graft
Additional conditions recognized in this trial
Myocardial Infarction
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Interventions listed in this trial
pexelizumab
Sponsors listed in this trial
Alexion Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services